Clinical Trials Logo

Cough clinical trials

View clinical trials related to Cough.

Filter by:

NCT ID: NCT01575821 Completed - Sleep Clinical Trials

The Effect of Honey on Nocturnal Cough and Sleep Quality

Start date: January 2009
Phase: N/A
Study type: Interventional

Cough is a common symptom in pediatric practice. It can be particularly troubling to children and their parents.It often results in discomfort to the child and loss of sleep to both the child and the parent. The objective of this trial was to compare the effects on nocturnal cough and the sleep difficulty associated with URIs of a single nocturnal dose of three different honey products compared to placebo

NCT ID: NCT01566968 Completed - Healthy Clinical Trials

Novel Endpoints in Cough Challenge Testing

NEAT
Start date: January 2011
Phase: N/A
Study type: Observational

The sensitivity of a person's cough reflex can be measured by getting them to breathe in (inhale) irritant chemicals. There are different methods by which subjects are asked to inhale these chemicals, either by taking one deep breath in, or by asking them to just continue to take a number of breaths. The purpose of this clinical research study is to see if the coughing responses are different in healthy people and people with respiratory problems that make them cough when they are given these chemicals in these two methods.

NCT ID: NCT01532466 Completed - Clinical trials for Fentanyl-induced Coughing

The Effect of Priming Intravenous Rocuronium on Fentanyl-Induced Coughing

Start date: March 2011
Phase: N/A
Study type: Interventional

An intravenous bolus of fentanyl often induces a cough reflex. This study investigates whether priming with rocuronium can attenuate fentanyl-induced coughing effectively.

NCT ID: NCT01515280 Completed - Cough Clinical Trials

Hull Airway Reflux Questionnaire Scores Following Cough Treatment

Start date: January 2012
Phase:
Study type: Observational

The aim of this study is to have those patients taking part in the Clinical trial-: A Multicentre, Double-Blind, Placebo-Controlled, Pivotal Study of the Efficacy and Safety of Oral Theobromine in the Management of Cough. Complete the Hull Airway Reflux Questionnaire (HARQ) at randomisation and repeat the questionnaire at the end of the 14 day treatment period. The investigators hope to demonstrate a clinically significant change in HARQ scores of at least 16 points from before and after treatment. Furthermore the investigators would hope to show a significantly improved HARQ score in patients on the BC036 arm of the study compared to the placebo arm.

NCT ID: NCT01507792 Completed - Cough Clinical Trials

Iron Repletion in Chronic Cough and Iron Deficiency

CID
Start date: January 2002
Phase: N/A
Study type: Interventional

Chronic cough is more frequent and severe in women than in men. Women often have decreased iron stores, due to menses and pregnancies. Aim of the study: to investigate if iron deficiency has a role in chronic cough by favouring airway hypersensitivity to inhaled irritants.

NCT ID: NCT01506583 Completed - Fatigue Clinical Trials

Clinical Evaluation of QFlu Combo Test

QFlu
Start date: November 1, 2010
Phase:
Study type: Observational

Currently effective antivials for influenza treatment are two influenza viral neuraminidase inhibitors, oseltamivir (Tamiflu) and zanamivir (Relenza). Resistance to these drugs is reflected by reduced susceptibility of viral neuraminidase to these drugs. The hypothesis is that the signal ratio of two reagents (with or without a single concentration of the drug) correlates the IC50 value, an accurate measurement of drug resistance but impractical for clinical use.

NCT ID: NCT01494636 Completed - Cough Clinical Trials

The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects

FTIH
Start date: October 17, 2011
Phase: Phase 1
Study type: Interventional

This is a First Time in Human (FTIH) study for the sodium channel inhibitor, GSK2339345. The study is split into two parts. Part A will assess the safety and tolerability of the new drug. Part B will assess safety and tolerability as well as the effect of GSK2339345 on induced cough.

NCT ID: NCT01489072 Completed - Anesthesia Clinical Trials

Efficacy of Two Bolus Doses of Remifentanil on the Incidence of Coughing During Emergence of Anesthesia

Start date: April 2012
Phase: N/A
Study type: Interventional

This study is designed to compare the effects of two bolus doses of intravenous remifentanil given prior to the emergence of anesthesia: - on the incidence of perioperative coughing - on the time needed for the emergence of a desflurane-based anesthesia - on the incidence of sore throat after extubation. The investigators hypothesis is that the use of a higher remifentanil bolus dose (0.5 mcg/kg) given prior to emergence of a desflurane-based anesthesia will reduce the incidence of perioperative coughing when compared to a lower dose of remifentanil (0.25 mcg/kg).

NCT ID: NCT01486394 Completed - Chest Pain Clinical Trials

Sonography in an Unselected Population of Acute Admitted Patients With Respiratory Symptoms

Start date: December 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether focused sonography of the heart, lungs and deep veins can increase the number of patients with respiratory symptoms correctly diagnosed in an emergency department.

NCT ID: NCT01451840 Completed - Anesthesia Clinical Trials

Efficacy of Alkalinized Lidocaine Compared to Remifentanil on the Incidence of Coughing During Emergence of Anesthesia

Start date: January 2012
Phase: N/A
Study type: Interventional

This study is designed to compare the effects of alkalinized lidocaine in the endotracheal tube cuff to a bolus dose of remifentanil given prior to the emergence of anesthesia: - on the incidence of perioperative coughing - on the time needed for the emergence of a desflurane-based anesthesia - on the incidence of sore throat after extubation. The investigators hypothesis is that the use of alkalinized lidocaine in the endotracheal tube cuff will reduce the incidence of perioperative coughing after a desflurane-based anesthesia.